A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
Status: | Active, not recruiting |
---|---|
Conditions: | Arthritis, Rheumatoid Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 4/17/2018 |
Start Date: | December 2016 |
End Date: | February 2019 |
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
The purpose of this study is to demonstrate similarity of NI-071 (proposed biosimilar to
infliximab) to US REMICADE® (reference product) in terms of safety and efficacy in patients
with rheumatoid arthritis (RA) not adequately responding to methotrexate (MTX).
infliximab) to US REMICADE® (reference product) in terms of safety and efficacy in patients
with rheumatoid arthritis (RA) not adequately responding to methotrexate (MTX).
Inclusion Criteria:
- Patients with a diagnosis of rheumatoid arthritis (RA) as defined by the 2010 ACR and
European League Against Rheumatism (EULAR) classification criteria
- Patients have active RA, as confirmed by the following criteria:
- ≥6 swollen joints and ≥6 tender joints at screening and baseline (28-joint count)
- Either C-reactive protein (CRP) ≥0.7 mg/dL (≥7.0 mg/L) or erythrocyte
sedimentation rate (ESR) ≥28 mm/h at screening
- Patients taking methotrexate (MTX) (oral or parenteral) for at least 3 months prior to
screening and at a stable dose of between 10 and 25 mg/week for at least 8 weeks.
Concomitant folic/folinic acid at a dose of at least 5 mg/week is to be taken during
the study; patients can start treatment with folic/folinic acid at screening if not
already receiving it.
- If the patient is currently taking non-steroidal anti-inflammatory drugs (NSAIDs), the
patient must be on a stable dose for at least 4 weeks prior to screening and during
the study.
- Patients who are ≥18 and ≤75 years of age at screening
Exclusion Criteria:
- Patients who are rated as Class IV according to the 1991 ACR revised criteria for
classification of global functional status for RA
- Patients who have received disease-modifying anti rheumatic drugs (DMARDs), other than
MTX, within a period prior to screening shorter than the washout period appropriate to
the pharmacodynamic profile of the specific drug
- Patients who have received immunosuppressive drugs within 4 weeks prior to screening.
Patients on a stable dose of oral corticosteroids (≤10 mg/day prednisone or
equivalent) for ≥4 weeks prior to screening are permitted.
- Patients who have received intra-articular, intramuscular, intravenous, or epidural
injection of corticosteroids within 4 weeks prior to screening
- Patients who have received intra-articular sodium hyaluronate injections within 4
weeks prior to screening
- Patients who have received surgical therapy for RA such as synovectomy or arthroplasty
within 6 months prior to screening
- Patients who have received arthrocentesis within 4 weeks prior to screening
- Patients who have had prior treatment with infliximab
- Patients who have had prior treatment with >1 biological drug or >1 protein kinase
inhibitor for RA either as part of clinical management or during a clinical study
- Patients who have had prior treatment with tumor necrosis factor alpha (TNF-α)
inhibitors for RA who had lack of efficacy as per clinical judgment (primary failure).
Patients who have discontinued TNF-α inhibitors for RA (other than infliximab) for any
reason other than lack of efficacy are allowed.
- Presence of chronic or acute infection at screening, including positive result for
active tuberculosis (TB)
- Patients with an acute infection requiring parenteral antibiotics within 4 weeks of
study dosing or requiring oral/topical antibiotics within 2 weeks of study dosing.
We found this trial at
59
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials